MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-18-0012930
Makellos Medications Private Limited
Makellos Medications Private Limited - trading in Noida, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹57.59 Lakh
▼ 7% YoY
Net profit · FY 2024
₹83,278
Net margin 1.4%
EBITDA · FY 2024
₹4.9 Lakh
EBITDA margin 8.5%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Makellos Medications Private Limited
Data last updated:
Makellos Medications Private Limited is a private limited company based in Noida, Uttar Pradesh, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 19 September 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U51909UP2016PTC086455. Its GSTIN is 09AAKCM5804H1ZA (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Madhav Gaur and Vandana Sharma.
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 88 Sector – 4, Noida, Uttar Pradesh, India – 201301.
As per the financials filed for FY 2024, the company reported a revenue of ₹57.59 Lakh, a decline of 7% compared to the previous year. For the same year it recorded a net profit of ₹83,278 (net margin 1.4%) and EBITDA of ₹4.9 Lakh (EBITDA margin 8.5%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 2% over five years.
Makellos Medications Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-18-0012930). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U51909UP2016PTC086455
Registration Number 086455
Incorporation Date 19 September 2016
ROC Uttar Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 26 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UP-18-0012930
Key People
Madhav Gaur Director Vandana Sharma Director Recognitions & Rankings of Makellos Medications
Contact details
Makellos Medications Private Limited's registered office is in Noida, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressA – 88 Sector – 4, Noida, Uttar Pradesh, India – 201301
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Makellos Medications Private Limited, buy the company report.
Comprehensive company report
Makellos Medications Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Makellos Medications is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Makellos Medications Private Limited, buy the company report.
Financials of Makellos Medications Private Limited
FY 2025 filings availableMakellos Medications Private Limited reported revenue of ₹57.59 Lakh (down 7% YoY) for FY 2024.
Revenue · FY 2024
₹57.59 Lakh ▼ 7%
Net profit · FY 2024
₹83,278 margin 1.4%
EBITDA · FY 2024
₹4.9 Lakh margin 8.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 7%
3 years · compounded
▲ 12%
5 years · compounded
▲ 2%
EBITDA CAGR growth
1 year
▲ 76%
3 years · compounded
▲ 72%
5 years · compounded
▲ 197%
Revenue fell 7% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 2%. EBITDA rose 76% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.9 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹83,278 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.5% | ||||
| Net Profit Margin | 1.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Makellos Medications Private Limited, buy the company report.
Board of directors of Makellos Medications Private Limited
Makellos Medications has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Madhav Gaur Also directs: Indovatan Solutions Private Limited | Director | 24 Jun 2022 | 4 Years 4 Months | Current |
| Vandana Sharma | Director | 19 Sep 2016 | 10 Years 1 Months | Current |
Peer comparison
Makellos Medications Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ralgan Life Sciences Private Limited | ₹57.6 Lakh (FY 2024) | -19.0% | Thane, Maharashtra, India | |||
| Mahadev Cashewnuts Private Limited | ₹57.6 Lakh (FY 2021) | -27.0% | Chatrapur, Odisha, India | |||
| Beyondinfinite.Com Semiconductor Private Limited | ₹57.59 Lakh (FY 2024) | 61.0% | New Delhi, Delhi, India | |||
| Barzan Enterprises Private Limited | ₹57.59 Lakh (FY 2024) | 19.0% | Kozhikode, Kerala, India | |||
| Shaafia Forex Private Limited | ₹57.59 Lakh (FY 2024) | -75.0% | Diu, Daman and Diu, India | |||
| Makellos Medications Private Limitedthis company | ₹57.59 Lakh (FY 2024) | ₹83,278 | 1.4% | -7.0% | Noida, Uttar Pradesh, India | |
| Redan Vetceuticals Private Limited | ₹57.59 Lakh (FY 2024) | 0.0% | New Delhi, Delhi, India | |||
| Orice International Private Limited | ₹57.58 Lakh (FY 2024) | -27.0% | Chennai, Tamil Nadu, India | |||
| Nexgen Remedies Private Limited | ₹57.57 Lakh (FY 2018) | -47.0% | Patna, Bihar, India | |||
| Ariskon Pharma Private Limited | ₹57.57 Lakh (FY 2024) | 48.0% | New Delhi, Delhi, India | |||
| Parsadisah Foods Private Limited | ₹57.56 Lakh (FY 2024) | Kolkata, West Bengal, India |
To see the full peer comparison of Makellos Medications Private Limited, buy the company report.
Auditor
Makellos Medications Private Limited is audited by GAURAV GOEL AND ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GAURAV GOEL AND ASSOCIATES | FY 2017 | 016712C |
Shareholding
The shareholding of Makellos Medications Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Makellos Medications Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Makellos Medications Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Makellos Medications Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Makellos Medications has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAKCM5804H1ZA | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Makellos Medications Private Limited, buy the company report.
Recent activity
Makellos Medications Private Limited has 5 board changes on record since 2016: 2 appointments and 3 cessations. The latest: Madhav Gaur ceased to be Additional Director on 30 Sep 2022.
AGM
Makellos Medications Private Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records.
Filing
Makellos Medications Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttar Pradesh Ii.
Ceased
Madhav Gaur ceased to be Additional Director.
Ceased
Kapil Malik ceased to be Director.
Appointed
Madhav Gaur was appointed as Director.
Ceased
Rakesh Agrawal ceased to be Additional Director.
Appointed
Vandana Sharma was appointed as Director.
Incorporation
19 Sep 2016
Makellos Medications Private Limited was registered on 19 Sep 2016 with Roc Uttar Pradesh Ii & aged 10 years 1 month as per MCA records.
Frequently asked questions
Makellos Medications is an active private limited company based in Noida, Uttar Pradesh, India. The company works in other wholesale, within the trading industry. It was incorporated on 19 September 2016 (10+ years old) and is registered under CIN U51909UP2016PTC086455.
Makellos Medications has 2 current directors:
- Madhav Gaur - Director
- Vandana Sharma - Director
The latest financial statements of Makellos Medications on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 26 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Makellos Medications is 09AAKCM5804H1ZA, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Makellos Medications is U51909UP2016PTC086455. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Makellos Medications was incorporated on 19 September 2016, making it 10+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Makellos Medications by revenue are Ralgan Life Sciences Private Limited, Mahadev Cashewnuts Private Limited, Beyondinfinite.Com Semiconductor Private Limited, Barzan Enterprises Private Limited, Shaafia Forex Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Madhav Gaur ceased to be Additional Director on 30 Sep 2022. Kapil Malik ceased to be Director on 24 Jun 2022. Madhav Gaur was appointed as Director on 24 Jun 2022. Makellos Medications has 5 board changes on record in total.
Yes, Makellos Medications is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-18-0012930).
The registered office of Makellos Medications is at A – 88 Sector – 4, Noida, Uttar Pradesh, India – 201301.
Makellos Medications operates in the trading industry, in the other wholesale segment.